Bio-Allay

NPN: 80057563

Item Code: 7857

Quantity: 120 capsules

Description: Neurologic function

Indications: Consider pain and inflammation

Ingredients: Proprietary Blend 900 mg
White Willow (Salix alba) (bark)
Devil’s Claw extract (Harpagophytum procumbens)(root)
Boswellia serrata extract (gum)

Suggestion: 2 capsules 2 times per day or as directed by a healthcare provider.

References: Independent research and related articles:
Vasquez A. Reducing pain and inflammation naturally - Part 3: Improving overall health while safely and effectively treating musculoskeletal pain. Nutritional Perspectives 2005; 28: 34-38, 40-42
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992 Jun;261( 3):1143-6
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomedicine. 2003 Jan;10( 1):3-7
Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3( 11):511-4
Gupta I, Parihar A, Malhotra P, Singh GB, Ludtke R, Safayhi H, Ammon HP. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997 Jan;2( 1):37-43
Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low-back pain: a systematic review. BMC Complement Altern Med. 2004 Sep 15;4( 1):13
Whitehouse LW, Znamirowska M, Paul CJ. Devil\'s Claw ( Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 1983 Aug 1;129( 3):249-51
Chantre P, Cappelaere A, Leblan D, Guedon D, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000;7( 3):177-83
Leblan D, Chantre P, Fournie B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 2000;67( 5):462-7
Chrubasik S, Model A, Black A, Pollak S. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low-back pain. Rheumatology ( Oxford). 2003 Jan;42( 1):141-8
Chrubasik S, Thanner J, Kunzel O, Conradt C, Black A, Pollak S. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip. Phytomedicine 2002 Apr;9( 3):181-94
Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low-back pain: a systematic review. BMC Complement Altern Med. 2004 Sep 15;4( 1):13
Chrubasik S, Conradt C, Black A. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine. 2003;10( 6-7):613-23
Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low-back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med. 2000;109:9-14

Chrubasik S, Kunzel O, Model A, Conradt C, Black A. Treatment of low-back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low-back pain. Rheumatology ( Oxford). 2001;40:1388-93